Inositol Supplementation to Treat PCOS (INSUPP-PCOS)

PHASE2RecruitingINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

January 24, 2020

Primary Completion Date

November 30, 2025

Study Completion Date

November 30, 2025

Conditions
Polycystic Ovary SyndromeAnovulationHyperandrogenismInsulin ResistanceGlucose IntoleranceMetabolic Complication
Interventions
OTHER

Placebo

Placebo

DRUG

Inositol

1gm/bid, 2gm/bid or 3gm/bid of Inositol powder

Trial Locations (2)

17033

RECRUITING

Penn State College of Medicine, Penn State Milton S. Hershey Medical Center, Hershey

19104

RECRUITING

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Center for Complementary and Integrative Health (NCCIH)

NIH

lead

Milton S. Hershey Medical Center

OTHER